Diabetes Genetics and Genomics

Diabetes Genetics and Genomics

Diabetes Genetics and Genomics

The Diabetes Genetics and Genomics program advances research to identify the genes that predispose individuals to develop type 1 or type 2 diabetes.  By determining the genetic mechanisms underlying these diseases—and how genetic and epigenetic variation influence therapeutic strategies—researchers should be able to develop better medications and therapies.  Studies can involve the use of animal models to identify the genes responsible for development of the disease; research to develop genetic resources; creation of animal models for therapeutic trials in type 1 diabetes; quantitative statistical and genetic methods to identify diabetes genes in human populations; investigation of the interactions of multiple genes and environmental factors; and research to examine the genetics underlying variation in response to diabetes drugs.  Also included in this program are studies that determine genetic differences between populations that result in health disparities.​​​​​

​​​​​​​​

NIDDK Staff   Beena Akolkar, Ph.D.Clinical research in the prevention of Type 1 Diabetes and the genetics and genomics of Type 1 and Type 2 DiabetesCatherine McKeon, Ph.D.Cystic fibrosis research and translation centers; inborn errors of metabolism; and genetics of type 2 diabetes Aaron Pawlyk, Ph.D.Key regulators of intermediary metabolism; drug discovery; pharmacogenetics and personalized medicine in the treatment of diabetes

Related Funding Opportunities

Research Resources

NIDDK Active Trials in Diabetes

Related Study Sections